Beranda0775 • HKG
add
CK Life Sciences Intl (Holdings) Inc
Tutup sebelumnya
$0,35
Rentang hari
$0,34 - $0,36
Rentang tahun
$0,30 - $0,80
Kapitalisasi pasar
3,46 M HKD
Volume Rata-Rata
2,47 jt
Rasio P/E
192,74
Hasil dividen
-
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (HKD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,87 jt | 87,14% |
Biaya operasional | 368,88 jt | 18.692,17% |
Laba bersih | 221,97 rb | 1.299,92% |
Margin laba bersih | 11,90 | 739,78% |
Penghasilan per saham | — | — |
EBITDA | 530,04 rb | 182,32% |
Tarif pajak efektif | 50,18% | — |
Neraca
Total aset
Total liabilitas
| (HKD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 99,49 jt | 17,57% |
Total aset | 141,84 jt | 7,10% |
Total liabilitas | 7,06 M | 6.004,35% |
Total ekuitas | 4,19 M | — |
Saham yang beredar | 9,61 M | — |
Harga terhadap reservasi | 0,78 | — |
Tingkat pengembalian aset | 0,88% | — |
Pengembalian modal | 5,77% | — |
Arus Kas
Perubahan bersih tunai
| (HKD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 221,97 rb | 1.299,92% |
Kas dari operasi | 5,11 jt | -93,17% |
Tunai dari investasi | -3,50 jt | -117,07% |
Tunai dari pembiayaan | -332,85 rb | 9,51% |
Perubahan bersih tunai | 1,28 jt | 101,65% |
Arus kas bebas | -124,65 rb | 79,52% |
Tentang
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector. Wikipedia
CEO
Didirikan
2000
Situs
Karyawan
120
